Safety and efficacy of down staging of neoadjuvant chemotherapy with modified FOLFOX6 (combination chemotherapy of infusional 5-FU/l-Leucovorin and intermittent oxaliplatin) with bevacizumab in patients with advanced lower rectal cancer .
Safety and efficacy of down staging of neoadjuvant chemotherapy with modified FOLFOX6 (combination chemotherapy of infusional 5-FU/l-Leucovorin and intermittent oxaliplatin) with bevacizumab in patients with advanced lower rectal cancer .
复制标题
改良 FOLFOX6（输注 5-FU/l-亚叶酸和间歇性奥沙利铂的联合化疗）联合贝伐珠单抗对晚期下位直肠癌患者进行降期新辅助化疗的安全性和有效性。
DOI：
--
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Ashizawa Y.
中科院分区：
文献类型：
--
作者：
Kosugi C;Koda K;Shimizu H;Yamazaki M;Shuto K;Nojima H;Murakami T;Ashizawa Y.
